PL377662A1 - Pregabalina i jej pochodne w leczeniu fibromialgii i innych zaburzeń pokrewnych - Google Patents

Pregabalina i jej pochodne w leczeniu fibromialgii i innych zaburzeń pokrewnych

Info

Publication number: PL377662A1
Authority: PL; Poland
Prior art keywords: pregabalin; fibromyalgia; derivates; treatment; related disorders
Prior art date: 2002-12-13

Application number

PL377662A

Other languages

English (en)

Inventor

Charles Price Taylor Jr.

Andrew John Thorpe

Fong Wang

David Juergen Wustrow

Original Assignee

Warner-Lambert Company Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-13

Filing date

2003-12-03

Publication date

2006-02-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32600152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL377662(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-03 Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc

2006-02-06 Publication of PL377662A1 publication Critical patent/PL377662A1/pl

Links

208000001640 Fibromyalgia Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
208000035475 disorder Diseases 0.000 title 1
AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 title 1
229960001233 pregabalin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL377662A 2002-12-13 2003-12-03 Pregabalina i jej pochodne w leczeniu fibromialgii i innych zaburzeń pokrewnych PL377662A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US43349102P	2002-12-13	2002-12-13
US48348203P	2003-06-27	2003-06-27

Publications (1)

Publication Number	Publication Date
PL377662A1 true PL377662A1 (pl)	2006-02-06

Family

ID=32600152

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL377662A PL377662A1 (pl)	2002-12-13	2003-12-03	Pregabalina i jej pochodne w leczeniu fibromialgii i innych zaburzeń pokrewnych

Country Status (11)

Country	Link
US (2)	US20040138305A1 (pl)
EP (1)	EP1572187A1 (pl)
JP (1)	JP2006511604A (pl)
KR (1)	KR100845932B1 (pl)
AU (1)	AU2003286300A1 (pl)
BR (1)	BR0317263A (pl)
CA (1)	CA2508297A1 (pl)
MX (1)	MXPA05006209A (pl)
PL (1)	PL377662A1 (pl)
TW (1)	TW200412939A (pl)
WO (1)	WO2004054565A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100491282B1 (ko)	1996-07-24	2005-05-24	워너-램버트 캄파니 엘엘씨	통증 치료용 이소부틸가바 및 그의 유도체
AU2004271796A1 (en) *	2003-09-12	2005-03-24	Warner-Lambert Company Llc	Combination comprising an alpha-2-delta ligand and an SSRI and/or SNRI for treatment of depression and anxiety disorders
RU2008135907A (ru) *	2006-03-06	2010-04-20	Пфайзер Продактс Инк. (Us)	Альфа-2-дельта лиганды для невосстановительного сна
EP1857836B1 (en) *	2006-05-15	2009-10-21	Eldim Sa	Device and method for discriminating cerenkov and scintillation radiation
WO2008073257A1 (en) *	2006-12-08	2008-06-19	Xenoport, Inc.	Use of prodrugs of gaba analogs for treating diseases
US7872046B2 (en)	2008-01-25	2011-01-18	Xenoport, Inc.	Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
JP5563483B2 (ja) *	2008-01-25	2014-07-30	ゼノポート，インコーポレイティド	アシロキシアルキルカルバメートプロドラッグの合成に使用されるアシロキシアルキルチオカーボネートの鏡像異性的な分解
WO2009094577A2 (en) *	2008-01-25	2009-07-30	Xenoport, Inc.	Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
EP2509596B1 (en)	2009-12-08	2019-08-28	Case Western Reserve University	Gamma aminoacids for treating ocular disorders
WO2013023155A1 (en)	2011-08-11	2013-02-14	Xenoport, Inc.	Anhydrous and hemihydrate crystalline forms of an (r)-baclofen prodrug, methods of synthesis and methods of use
US10004710B2 (en) *	2013-01-18	2018-06-26	Kemphys Ltd.	Medicament for therapeutic treatment of neuropathic disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2460891C2 (de) *	1974-12-21	1982-09-23	Gödecke AG, 1000 Berlin	1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) *	1974-12-21	1978-05-02	Warner-Lambert Company	Treatment of cranial dysfunctions using novel cyclic amino acids
US6197819B1 (en) *	1990-11-27	2001-03-06	Northwestern University	Gamma amino butyric acid analogs and optical isomers
US6372792B1 (en) *	1996-04-26	2002-04-16	Guy Chouinard	Method for treating anxiety, anxiety disorders and insomnia
KR100491282B1 (ko) *	1996-07-24	2005-05-24	워너-램버트 캄파니 엘엘씨	통증 치료용 이소부틸가바 및 그의 유도체
ATE361909T1 (de) *	1996-10-23	2007-06-15	Warner Lambert Co	Substituierte gamma-aminobuttersäurederivate als arzneimittel
WO1999008670A1 (en) *	1997-08-20	1999-02-25	Guglietta, Antonio	Gaba analogs to prevent and treat gastrointestinal damage
EP0974351A3 (en) *	1998-04-24	2000-12-13	Jouveinal	Medicament for preventing and treating gastrointestinal damage
WO1999061424A1 (en) *	1998-05-26	1999-12-02	Warner-Lambert Company	Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
JP2002520277A (ja) *	1998-07-09	2002-07-09	ワーナー−ランバート・カンパニー	不眠症を治療する方法
DK1121114T3 (da) *	1998-10-16	2007-04-10	Warner Lambert Co	Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser
US6627771B1 (en) *	1998-11-25	2003-09-30	Pfizer Inc	Gamma amino butyric and acid analogs
WO2000067742A2 (en) *	1999-05-05	2000-11-16	Warner-Lambert Company	Use of gaba analogues for the modulation of substance p
JP3904452B2 (ja) *	1999-06-10	2007-04-11	ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー	モノ−およびジ置換３−プロピルガンマ−アミノ酪酸
WO2002100347A2 (en) *	2001-06-11	2002-12-19	Xenoport, Inc.	Prodrugs of gaba analogs, compositions and uses thereof
US6635675B2 (en) *	2001-11-05	2003-10-21	Cypress Bioscience, Inc.	Method of treating chronic fatigue syndrome
US20060167032A1 (en) *	2002-01-16	2006-07-27	Galer Bradley S	Pharmaceutical composition and method for treating disorders of the central nervous system

2003
- 2003-12-03 EP EP03777043A patent/EP1572187A1/en not_active Withdrawn
- 2003-12-03 AU AU2003286300A patent/AU2003286300A1/en not_active Abandoned
- 2003-12-03 KR KR1020057010503A patent/KR100845932B1/ko not_active Expired - Fee Related
- 2003-12-03 MX MXPA05006209A patent/MXPA05006209A/es unknown
- 2003-12-03 WO PCT/IB2003/005684 patent/WO2004054565A1/en not_active Ceased
- 2003-12-03 PL PL377662A patent/PL377662A1/pl not_active Application Discontinuation
- 2003-12-03 BR BR0317263-5A patent/BR0317263A/pt not_active IP Right Cessation
- 2003-12-03 JP JP2005502468A patent/JP2006511604A/ja not_active Withdrawn
- 2003-12-03 CA CA002508297A patent/CA2508297A1/en not_active Abandoned
- 2003-12-09 US US10/731,225 patent/US20040138305A1/en not_active Abandoned
- 2003-12-12 TW TW092135200A patent/TW200412939A/zh unknown
2007
- 2007-05-18 US US11/804,789 patent/US20070238749A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR0317263A (pt)	2005-11-08
MXPA05006209A (es)	2005-08-19
JP2006511604A (ja)	2006-04-06
US20040138305A1 (en)	2004-07-15
WO2004054565A8 (en)	2004-09-10
EP1572187A1 (en)	2005-09-14
TW200412939A (en)	2004-08-01
US20070238749A1 (en)	2007-10-11
WO2004054565A1 (en)	2004-07-01
KR100845932B1 (ko)	2008-07-11
CA2508297A1 (en)	2004-07-01
AU2003286300A1 (en)	2004-07-09
KR20050084236A (ko)	2005-08-26

Legal Events

Date	Code	Title	Description
2010-09-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
ZA200504724B (en)	2009-01-28	Pregabalin derivatives for the treatment of fibromyalgia and other disorders
IL210090A0 (en)	2011-07-31	TREATMENT OF TNFa RELATED DISORDERS
IL175055A0 (en)	2008-04-13	Combinations useful for the treatment of neuronal disorders
IL208191A0 (en)	2010-12-30	Compositions and methods for treating rage-associated disorders
PT1644021E (pt)	2013-01-30	Métodos e composições para o tratamento de distúrbios gastrointestinais
AU2003286567A8 (en)	2004-05-13	Methods for the treatment of skin disorders
AU2003233583A1 (en)	2003-12-12	Oral lactoferrin in the treatment of respiratory disorders
IL159771A0 (en)	2004-06-20	Combinations for the treatment of inflammatory disorders
EP1509279A4 (en)	2009-10-28	DEVICE AND METHOD FOR THE TREATMENT OF HEART DISEASES
IL175529A0 (en)	2006-09-05	Methods and compositions for the treatment of metabolic disorders
HUS1600050I1 (hu)	2017-06-28	Eljárás szklerózis multiplex kezelésére
HRP20040906B1 (en)	2013-01-31	Bisphosphonic acid for the treatment and prevention of ostreoporosis
AU2003213787A1 (en)	2003-09-22	Compositions and methods for the treatment of anorectal disorders
AU2003228819A8 (en)	2003-11-17	Combinations for the treatment of inflammatory skin disorders
EP1567198A4 (en)	2006-05-31	MATERIALS AND METHOD FOR THE TREATMENT OF EYE DISEASES
EP1478438A4 (en)	2007-11-14	TECHNIQUES AND COMPOSITIONS FOR THE TREATMENT OF ASTHMA AND RELATED DISORDERS
PL377662A1 (pl)	2006-02-06	Pregabalina i jej pochodne w leczeniu fibromialgii i innych zaburzeń pokrewnych
AU2002356276A8 (en)	2003-07-09	Quinline derivates and their use as mek inhibitors
IL175610A0 (en)	2006-09-05	Methods and reagents for the treatment of inflammatory disorders
PL377520A1 (pl)	2006-02-06	Pochodne pregabaliny przeznaczone do leczenia fibromialgii i innych zaburzeń
EP1549141A4 (en)	2008-06-25	METHOD AND COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES USING CLOFARABIN
PL377286A1 (pl)	2006-01-23	Analogi gabapentyny do włókniako-mięśniakowych i innych pokrewnych zaburzeń
EP1539100A4 (en)	2006-01-18	COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
HRP20041160A2 (en)	2005-08-31	Novel combination for the treatment of airway disorders
SI1553967T1 (sl)	2011-07-29	Uporaba amid derivata GE 2270 faktorja A3 za zdravljenje aken